Propanc Biopharma, Inc. Common Stock (PPCB) — Cash Flow-to-Debt Ratio
Propanc Biopharma, Inc. Common Stock (PPCB) has a Cash Flow-to-Debt Ratio of -0.25x as of March 2026, meaning its operating cash flow of $-1.14 Million could theoretically repay 0% of its total liabilities ($4.51 Million) in one year. Explore Propanc Biopharma, Inc. Common Stock long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Propanc Biopharma, Inc. Common Stock Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Propanc Biopharma, Inc. Common Stock across 16 annual periods. Also explore PPCB current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Propanc Biopharma, Inc. Common Stock (2010–2025)
Year-by-year debt coverage analysis for Propanc Biopharma, Inc. Common Stock. For market capitalisation and broader financial context, see Propanc Biopharma, Inc. Common Stock (PPCB) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | $-405.17K | $5.73 Million | ▲ +70.9% |
| 2024 | -0.24x | $-935.12K | $3.85 Million | ▲ +30.2% |
| 2023 | -0.35x | $-1.11 Million | $3.18 Million | ▲ +24.8% |
| 2022 | -0.46x | $-1.44 Million | $3.11 Million | ▼ -24.4% |
| 2021 | -0.37x | $-1.15 Million | $3.08 Million | ▲ +24.8% |
| 2020 | -0.49x | $-1.85 Million | $3.74 Million | ▼ -5.7% |
| 2019 | -0.47x | $-2.06 Million | $4.40 Million | ▼ -46.6% |
| 2018 | -0.32x | $-2.18 Million | $6.82 Million | ▲ +17.9% |
| 2017 | -0.39x | $-2.15 Million | $5.54 Million | ▲ +76.2% |
| 2016 | -1.63x | $-4.80 Million | $2.94 Million | ▼ -320.6% |
| 2015 | -0.39x | $-1.43 Million | $3.68 Million | ▼ -160.5% |
| 2014 | -0.15x | $-226.44K | $1.52 Million | ▲ +8.2% |
| 2013 | -0.16x | $-128.65K | $794.22K | ▲ +44.4% |
| 2012 | -0.29x | $-170.28K | $584.19K | ▲ +93.6% |
| 2011 | -4.55x | $-1.40 Million | $306.85K | ▼ -448.0% |
| 2010 | -0.83x | $-191.51K | $230.76K | — |